# Lingzhi for Cancer Children

> **NCT00575926** · PHASE3 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 58 (actual)

## Conditions studied

- Pediatric Cancers

## Interventions

- **DRUG:** LingZhi capsule

## Key facts

- **NCT ID:** NCT00575926
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2007-12-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00575926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00575926, "Lingzhi for Cancer Children". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00575926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*